NLRP3 Antibody - N-terminal region

Catalog Number: ASB-ARP63297_P050
Article Name: NLRP3 Antibody - N-terminal region
Biozol Catalog Number: ASB-ARP63297_P050
Supplier Catalog Number: ARP63297_P050
Alternative Catalog Number: ASB-ARP63297_P050-25UL,ASB-ARP63297_P050-100UL
Manufacturer: Aviva
Host: Rabbit
Category: Proteine/Peptide
Application: WB
Species Reactivity: Bovine, Canine, Equine, Human, Porcine, Rabbit
Alternative Names: AII, AVP, FCU, MWS, FCAS, KEFH, CIAS1, FCAS1, NALP3, C1orf7, CLR1.1, DFNA34, PYPAF1, AGTAVPRL
This gene encodes a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NALP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis. Mutations in this gene are associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, and neonatal-onset multisystem inflammatory disease (NOMID).
Clonality: Polyclonal
Concentration: 0.5 mg/ml
Molecular Weight: 114kDa
NCBI: 114548
UniProt: Q96P20
Form: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
WB Suggested Anti-NLRP3 Antibody
Titration: 1.0 ug/ml
Positive Control: Fetal Kidney
Lanes:
Lane 1: 30ug human glioma lysate
Lane 2: 30ug IL-1 treated human glioma lysate
Primary Antibody Dilution:
1:500
Secondary Antibody:
Anti-rabbit-HRP
Secondary Antibody Dilution:
1:500
Gene Name:
NLRP3
Submitted by:
Anonymous
Surface Plasmon Resonance Kinetic Characterization of Polyclonal Antibody Affinity. Purified polyclonal antibodies were immobilized on a Protein A/G coated Carterra LSA sensor chip (PAGH200M) at concentrations of 5, and 50 ug/mL in duplicate. Antibodies on the surface were exposed to interaction with peptides sequentially via microfluidic controlled flow at 333nM peptide concentration for kinetic characterization of the binders for affinity and specificity, followed by curve fitting using the Kinetics software. Kd determinations for both concentrations were averaged and results and standard deviation are shown.
NLRP3 antibody - N-terminal region (ARP63297_P050) in Human Fetal Kidney using Western Blot